Table 1 Characteristics of lymph node stations at 18F-Alfatide PET/CT.

From: A Pilot Study of 18F-Alfatide PET/CT Imaging for Detecting Lymph Node Metastases in Patients with Non-Small Cell Lung Cancer

Variables

NSCLC

AC

SCC

Malignant

Benign

P

Malignant

Benign

P

Malignant

Benign

P

SUVmax

2.5(1.1–3.8)

0.9(0.3–3.3)

<0.01

1.8(1.1–3.8)

0.95(0.3–2.5)

<0.01

1.7(1.4–2.2)

0.9(0.4–3.3)

<0.01

SUVmean

1.7(0.9–2.5)

0.8(0.3–2.6)

<0.01

1.45(0.9–2.5)

0.9(0.3–1.8)

<0.01

1.3(1.1–1.8)

0.8(0.4–2.6)

<0.01

SUVLN/PT

0.5(0.2–0.9)

0.2(0.1–1.0)

<0.01

0.31(0.2–0.6)

0.24(0.1–1.0)

<0.01

0.3(0.27–0.4)

0.2(0.1–0.6)

<0.01

SUVLN/MBP

2.2(0.8–3.5)

0.9(0.3–3.0)

<0.01

1.1(0.8–3.2)

0.8(0.4–2.2)

<0.01

1.9(1.6–2.0)

1.0(0.4–3.0)

<0.01

SUVLN/M

4.1(2.2–9.5)

1.7(0.6–4.7)

<0.01

3.0(2.2–9.8)

1.7(0.6–4.2)

<0.01

3.0(2.8–3.4)

1.6(0.8–4.7)

<0.01

  1. All data represent median (range). NSCLC, non-small cell lung cancer; AC, adenocarcinoma; SCC, squamous cell carcinoma; P, P value; SUV, standardized uptake value; LN, lymph node; MBP, mediastinal blood pool; PT, primary tumor; M, muscle.